Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CGC logo CGC
Upturn stock ratingUpturn stock rating
CGC logo

Canopy Growth Corp (CGC)

Upturn stock ratingUpturn stock rating
$2.74
Delayed price
upturn advisory
PASS
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

12/31/2024: CGC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -74.82%
Avg. Invested days 17
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/31/2024

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 408.10M USD
Price to earnings Ratio -
1Y Target Price 3.24
Price to earnings Ratio -
1Y Target Price 3.24
Volume (30-day avg) 4841726
Beta 1.78
52 Weeks Range 2.65 - 14.92
Updated Date 12/31/2024
52 Weeks Range 2.65 - 14.92
Updated Date 12/31/2024
Dividends yield (FY) -
Basic EPS (TTM) -4.95

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -201.27%
Operating Margin (TTM) -33.63%

Management Effectiveness

Return on Assets (TTM) -4.39%
Return on Equity (TTM) -93.03%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 601007789
Price to Sales(TTM) 1.45
Enterprise Value 601007789
Price to Sales(TTM) 1.45
Enterprise Value to Revenue 3.09
Enterprise Value to EBITDA -1.06
Shares Outstanding 122394000
Shares Floating 105241167
Shares Outstanding 122394000
Shares Floating 105241167
Percent Insiders 0.17
Percent Institutions 8.49

AI Summary

Canopy Growth Corp.: A Comprehensive Overview

Company Profile:

History and Background:

Canopy Growth Corp. (CGC) is a Canadian cannabis company founded in 2013. It operates in the medical and recreational cannabis markets, offering a range of products including dried flower, oils, edibles, and beverages. The company has a global presence, with operations in Canada, the United States, Europe, and Latin America.

Core Business Areas:

  • Cultivation and Production: Canopy Growth operates numerous cannabis cultivation facilities and production plants across Canada and around the world.
  • Research and Development: The company invests heavily in research and development to improve its products and develop new ones.
  • Distribution and Sales: Canopy Growth sells its products through various channels, including retail stores, online platforms, and medical dispensaries.
  • Strategic Partnerships: They have formed strategic partnerships with key industry players like Constellation Brands and Acreage Holdings to expand their market reach and expertise.

Leadership Team and Corporate Structure:

  • David Klein (Executive Chairman): Former CEO of Constellation Brands, he brings extensive experience in consumer goods and brand building.
  • Peter Aceto (CEO): A seasoned executive with experience in the food and beverage industry, he leads the company's operational and strategic direction.
  • Mike Lee (CFO): An experienced finance professional, he oversees the company's financial strategy and performance.

Top Products and Market Share:

Top Products:

  • Dried Flower: CGC offers a wide range of popular dried flower strains under brands like Tweed, Tokyo Smoke, and Quatreau.
  • Oils: Their portfolio includes various cannabis oil products for medical and recreational use.
  • Edibles: Canopy Growth offers gummies, chocolates, and other edible cannabis products.
  • Beverages: They have partnered with companies like Molson Coors to develop cannabis-infused beverages.

Market Share:

  • Global: CGC holds a significant market share in the global cannabis market, estimated to be around 5-10%.
  • US: The company holds a smaller market share in the US market, estimated to be around 2-3%.
  • Competition: CGC faces competition from other major cannabis companies like Tilray, Aphria, and Cronos Group.

Total Addressable Market:

The global cannabis market is expected to reach $70.6 billion by 2025, making it a highly attractive market for companies like Canopy Growth. The increasing legalization of cannabis in various countries is driving market growth.

Financial Performance:

Recent Financial Statements:

  • Revenue: Revenue has been increasing steadily in recent years, reaching C$547 million in 2022.
  • Net Income: The company has been consistently reporting net losses, with a net loss of C$717 million in 2022.
  • Profit Margins: Profit margins remain negative due to high operating costs and ongoing investments.
  • Earnings per Share (EPS): CGC does not have positive EPS as it has not yet achieved profitability.

Financial Performance Comparison:

  • Year-over-Year: Revenue is growing, but net losses are also increasing.
  • Cash Flow & Balance Sheet: CGC has a strong cash position and a relatively healthy balance sheet.

Dividends and Shareholder Returns:

Dividend History:

CGC does not currently pay dividends.

Shareholder Returns:

Shareholder returns have been negative in recent years due to the company's declining stock price.

Growth Trajectory:

Historical Growth:

Revenue has grown significantly in recent years, but the company has not yet achieved profitability.

Future Growth Projections:

Analysts expect CGC to continue experiencing revenue growth in the coming years as the cannabis market expands. However, achieving profitability remains a key challenge.

Recent Initiatives:

CGC is focusing on improving its operational efficiency, expanding its product portfolio, and entering new markets to drive future growth.

Market Dynamics:

Industry Trends:

  • Legalization of cannabis in more countries is a major driver of market growth.
  • Increasing demand for premium cannabis products is another key trend.
  • Technological advancements are playing a significant role in the industry's development.

Company Positioning:

CGC is well-positioned in the cannabis market due to its size, brand recognition, and global presence. However, the company faces stiff competition and needs to improve its profitability.

Competitors:

Key Competitors:

  • Tilray (TLRY)
  • Aphria (APHA)
  • Cronos Group (CRON)
  • Aurora Cannabis (ACB)

Market Share:

  • CGC holds a larger market share than most of its competitors.
  • Competition is fierce, and market share varies depending on the product category and geographic market.

Competitive Advantages/Disadvantages:

  • CGC's advantages: Strong brand recognition, global presence, and strategic partnerships.
  • CGC's disadvantages: High operating costs, negative profitability, and intense competition.

Potential Challenges and Opportunities:

Key Challenges:

  • achieving profitability
  • managing competition
  • navigating regulatory changes
  • securing funding

Potential Opportunities:

  • entering new markets
  • developing new products
  • forming strategic partnerships

Recent Acquisitions (last 3 years):

  • Supreme Cannabis (2021): This acquisition expanded CGC's product portfolio and distribution network in Canada.
  • Ace Valley (2021): This acquisition provided CGC with additional cultivation capacity and strengthened its presence in the US market.
  • Wana Brands (2022): This acquisition made CGC the largest cannabis edibles company in North America.

AI-Based Fundamental Rating:

Rating: 5/10

Justification:

  • CGC has a strong market position and growth potential, but its lack of profitability and intense competition are major concerns.
  • The company has a strong cash position and a healthy balance sheet, which are positive factors.
  • The future success of CGC will depend on its ability to improve its operational efficiency, achieve profitability, and capitalize on new market opportunities.

Sources and Disclaimers:

Sources:

  • Canopy Growth Corp. Investor Relations website
  • Statista
  • Yahoo Finance
  • Globe and Mail

Disclaimer:

This information is for educational purposes only and should not be considered financial advice. Investing in the stock market involves risk, and you could lose money. Please consult with a financial professional before making any investment decisions.

Conclusion:

Canopy Growth Corp. is a leading cannabis company with a strong market position and growth potential. However, the company faces several challenges, including achieving profitability and managing competition. The future success of CGC will depend on its ability to navigate these challenges and capitalize on new market opportunities.

About NVIDIA Corporation

Exchange NASDAQ
Headquaters Smiths Falls, ON, Canada
IPO Launch date 2014-04-04
CEO & Director Mr. David Eric Klein
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 1029
Full time employees 1029

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​